ARTÍCULO ORIGINAL
Gefitinib concurrente con quimiorradiación en el cáncer de cabeza y cuello localmente avanzado
Gefitinib with concurrent chemoradiation in locally advanced head and neck cancer
Surendra Kumar Saini
, Shely Srivastava, Awadhesh Kumar Dixit
Autor para correspondencia
drsurensaini@gmail.com
Autor para correspondencia. Department of Radiotherapy and Oncology, G G Govt Hospital and MP Shah Medical College, Jamnagar 361008, Gujarat, India.
Autor para correspondencia. Department of Radiotherapy and Oncology, G G Govt Hospital and MP Shah Medical College, Jamnagar 361008, Gujarat, India.
Departamento de Radioterapia y Oncología, J.K. Cancer Institute, Kanpur, Uttarpradesh, India
Leído
3333
Vecesse ha leído el artículo
727
Total PDF
2606
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 15 | 4 | 19 |
| 2025 11 | 31 | 13 | 44 |
| 2025 10 | 23 | 7 | 30 |
| 2025 9 | 25 | 12 | 37 |
| 2025 8 | 20 | 6 | 26 |
| 2025 7 | 30 | 4 | 34 |
| 2025 6 | 25 | 3 | 28 |
| 2025 5 | 21 | 3 | 24 |
| 2025 4 | 16 | 6 | 22 |
| 2025 3 | 33 | 5 | 38 |
| 2025 2 | 30 | 9 | 39 |
| 2025 1 | 19 | 0 | 19 |
| 2024 12 | 26 | 5 | 31 |
| 2024 11 | 30 | 5 | 35 |
| 2024 10 | 34 | 2 | 36 |
| 2024 9 | 40 | 5 | 45 |
| 2024 8 | 30 | 5 | 35 |
| 2024 7 | 38 | 6 | 44 |
| 2024 6 | 19 | 3 | 22 |
| 2024 5 | 22 | 2 | 24 |
| 2024 4 | 34 | 3 | 37 |
| 2024 3 | 36 | 6 | 42 |
| 2024 2 | 31 | 5 | 36 |
| 2024 1 | 31 | 6 | 37 |
| 2023 12 | 23 | 7 | 30 |
| 2023 11 | 32 | 10 | 42 |
| 2023 10 | 45 | 6 | 51 |
| 2023 9 | 23 | 0 | 23 |
| 2023 8 | 27 | 3 | 30 |
| 2023 7 | 13 | 6 | 19 |
| 2023 6 | 30 | 0 | 30 |
| 2023 5 | 47 | 1 | 48 |
| 2023 4 | 26 | 0 | 26 |
| 2023 3 | 56 | 1 | 57 |
| 2023 2 | 34 | 3 | 37 |
| 2022 1 | 38 | 7 | 45 |
| 2022 12 | 55 | 6 | 61 |
| 2022 11 | 50 | 6 | 56 |
| 2022 10 | 20 | 9 | 29 |
| 2022 9 | 30 | 12 | 42 |
| 2022 8 | 29 | 4 | 33 |
| 2022 7 | 17 | 5 | 22 |
| 2022 6 | 24 | 9 | 33 |
| 2022 5 | 27 | 7 | 34 |
| 2022 4 | 18 | 8 | 26 |
| 2022 3 | 26 | 8 | 34 |
| 2022 2 | 35 | 4 | 39 |
| 2021 1 | 48 | 8 | 56 |
| 2021 12 | 23 | 12 | 35 |
| 2021 11 | 27 | 11 | 38 |
| 2021 10 | 37 | 15 | 52 |
| 2021 9 | 39 | 8 | 47 |
| 2021 8 | 26 | 10 | 36 |
| 2021 7 | 16 | 7 | 23 |
| 2021 6 | 21 | 8 | 29 |
| 2021 5 | 34 | 5 | 39 |
| 2021 4 | 64 | 12 | 76 |
| 2021 3 | 34 | 6 | 40 |
| 2021 2 | 11 | 7 | 18 |
| 2020 1 | 20 | 8 | 28 |
| 2020 12 | 26 | 2 | 28 |
| 2020 11 | 14 | 6 | 20 |
| 2020 10 | 11 | 3 | 14 |
| 2020 9 | 23 | 9 | 32 |
| 2020 8 | 18 | 5 | 23 |
| 2020 7 | 20 | 9 | 29 |
| 2020 6 | 22 | 8 | 30 |
| 2020 5 | 10 | 3 | 13 |
| 2020 4 | 10 | 1 | 11 |
| 2020 3 | 18 | 4 | 22 |
| 2020 2 | 16 | 6 | 22 |
| 2020 1 | 11 | 4 | 15 |
| 2019 12 | 15 | 6 | 21 |
| 2019 11 | 8 | 2 | 10 |
| 2019 10 | 13 | 3 | 16 |
| 2019 9 | 10 | 3 | 13 |
| 2019 8 | 10 | 2 | 12 |
| 2019 7 | 6 | 12 | 18 |
| 2019 6 | 26 | 19 | 45 |
| 2019 5 | 97 | 40 | 137 |
| 2019 4 | 37 | 25 | 62 |
| 2019 3 | 4 | 9 | 13 |
| 2019 2 | 4 | 2 | 6 |
| 2019 1 | 4 | 9 | 13 |
| 2018 12 | 7 | 2 | 9 |
| 2018 11 | 8 | 13 | 21 |
| 2018 10 | 9 | 6 | 15 |
| 2018 9 | 20 | 0 | 20 |
| 2018 8 | 3 | 7 | 10 |
| 2018 7 | 6 | 3 | 9 |
| 2018 6 | 1 | 3 | 4 |
| 2018 5 | 3 | 13 | 16 |
| 2018 4 | 8 | 0 | 8 |
| 2018 3 | 5 | 3 | 8 |
| 2018 2 | 3 | 1 | 4 |
| 2018 1 | 10 | 2 | 12 |
| 2017 12 | 5 | 3 | 8 |
| 2017 11 | 10 | 0 | 10 |
| 2017 10 | 4 | 1 | 5 |
| 2017 9 | 7 | 6 | 13 |
| 2017 8 | 7 | 0 | 7 |
| 2017 7 | 20 | 2 | 22 |
| 2017 6 | 9 | 2 | 11 |
| 2017 5 | 13 | 3 | 16 |
| 2017 4 | 12 | 0 | 12 |
| 2017 3 | 15 | 63 | 78 |
| 2017 2 | 15 | 2 | 17 |
| 2016 1 | 11 | 2 | 13 |
| 2016 12 | 18 | 1 | 19 |
| 2016 11 | 23 | 10 | 33 |
| 2016 10 | 29 | 15 | 44 |
| 2016 9 | 48 | 3 | 51 |
| 2016 8 | 39 | 4 | 43 |
| 2016 7 | 21 | 1 | 22 |
Mostrar todo